Company

Cytovation

Biotechnology Research Bergen, Vestland, No 12 employees

Employees: 12
Contacts: 3
Emails: 3
Phones: 3

cytovation.com LinkedIn

Cytovation Overview

Headquarters: Bergen, Vestland, No
Website: cytovation.com
Industry: Biotechnology Research
Employees: 12
Founded: 2015
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotech Oncology Immuno-oncology

About Cytovation

Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CY-101, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CY-101 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CY-101 to POC/pivotal clinical development with a focus on b-catenin-driven cancers.

Cytovation Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Cytovation Org Chart

Sample employees and titles

Name	Title	Location	Contact
Moti Vyas	Investor in Tanvi Foods (India) Ltd.	Edison, New Jersey, United States	Email Phone
Hilde Hukkelberg	Managing Director Uk & Ireland	Greater London, England, United Kingdom	Email Phone
Ellen Lubman		Manhattan Beach, California, United States	Email Phone
Rajnesh Airey	Partner @ Convergence Partners Ag		View